Anushua Sinha | Sr Principal Scientist, Clinical Research
Merck and Co.

Anushua Sinha is a Senior Principal Scientist in Global Clinical Development at Merck & Co. She is the Clinical Sciences Team Lead for the clesrovimab program. She completed her clinical training in internal medicine, pediatrics and infectious diseases at Massachusetts General Hospital and the Brigham and Women’s Hospital. She received her MD and MPH from Harvard Medical School and Harvard T.H. Chan School of Public Health. Prior to joining Merck in 2016, she was on the faculty at Rutgers, The State University of New Jersey, where she practiced clinical infectious diseases and led a vaccines-focused outcomes research group.